期刊文献+

胸腔积液肝素结合蛋白检测对肺炎旁胸腔积液鉴别诊断的临床价值 被引量:16

The differential diagnostic value of pleural effusion heparin-binding protein in parapneumonic effusion
原文传递
导出
摘要 目的探讨胸腔积液肝素结合蛋白(HBP)检测在胸腔积液患者中对肺炎旁胸腔积液(PPE)鉴别诊断的应用价值。方法病例对照研究。收集2018年2至7月在衢州市人民医院住院的189例胸腔积液患者的胸腔积液标本,其中肺炎旁胸腔积液(肺炎组)72例,结核性胸腔积液(结核组)24例,恶性胸腔积液(恶性组)46例,其他原因引起的漏出液(漏出液组)47例。对所有胸腔积液进行常规分析和胸腔积液乳酸脱氢酶(LDH)、胸腔积液腺苷脱氨酶(ADA)、胸腔积液总蛋白(TP)检测,并采用酶联免疫吸附法测定胸腔积液HBP水平。各组总体水平差异采用Kruskal-Wallis H检验,方差齐性多组比较采用单因素方差分析,方差不齐多组比较采用LSD检验,计数资料比较采用卡方检验。绘制ROC曲线评价胸腔积液中HBP、LDH、ADA、TP水平在PPE鉴别诊断中的应用。结果胸腔积液HBP浓度在肺炎组为316.1(99.5,399.8)ng/ml,结核组为64.7(18.6,96.8)ng/ml,恶性组15.2(8.4,33.3)ng/ml,漏出液组14.1(6.5,23.0)ng/ml。肺炎组胸腔积液HBP水平与其他3组之间比较,差异有统计学意义(H=120.3,P〈0.05)。当cut-off值为64.2 ng/ml时受试者工作特征(ROC)曲线下面积为0.953,灵敏度为88.9%(64/72),特异度为89.7%(105/117),阳性预测值为84.2%(64/76),阴性预测值为92.9%(105/113),总符合率为89.4%(169/189)。结论胸腔积液HBP水平诊断效能高,能较好区分胸腔积液患者的PPE,可能是PPE鉴别诊断的生物标志物。 ObjectiveThe aim of this study was to evaluate the value of pleural effusion heparin-binding protein(HBP)in differential diagnosis of parapneumonic effusion.MethodsCase-control study. The pleural effusion of 189 patients with pleural effusion admitted to Quzhou People′s Hospital from February to July 2018, including parapneumonic effusion (n=72), tuberculous pleural effusion(n=24), cases of malignant pleural effusion (n=46) and transudative pleural effusion (n=47) were collected. Routine analysis, lactate dehydrogenase(LDH), adenosine deaminase (ADA) and total protein(TP)examination of all pleural effusions were performed. The levels of heparin-binding protein in the patients′ pleural fluid were measured by ELISA. The difference in the overall level of each group was determined by One-way ANOVA or LSD test followed by Kruskal-Wallis H test dependence on the homogeneity of variances. The categorical data was analyzed by chi-square test.Receiver operating characteristic (ROC) curve was plotted to evaluate the diagnostic value of heparin-binding protein for parapneumonic effusion.ResultsThe concentration of heparin-binding protein was low in malignant pleural effusion[15.2(8.4, 33.3)ng/ml]and transudative effusion[14.1(6.5, 23.0)ng/ml], but high in parapneumonic effusion[316.1(99.5, 399.8)ng/ml]and tuberculous pleurisy[64.7 (18.6, 96.8) ng/ml]. The heparin-binding protein level in parapneumonic effusion was significantly different from the other three groups (H=120.3, P〈0.05). The receiver operating characteristic curve analysis for an optimal discrimination between parapneumonic effusion from non-parapneumonic effusion could be performed at a cut-off point of 64.2 ng/ml with area under the curve of 0.953[sensitivity: 88.9%(64/72), specificity: 89.7%(105/117), positive predictive value: 84.2%(64/76), negative predictive value: 92.9%(105/113)].ConclusionsHeparin-binding proteinin pleural fluid is effective to be used to classify parapneumonic effusion samples. The detection of heparin-binding protein in pleural effusion has good sensitivity and specificity. It could be a biomarker for differential diagnosis of parapneumonic effusion.
作者 张莉 白永凤 蒋峻梅 祝进 Zhang Li;Bai Yongfeng;Jiang Junmei;Zhu Jin(The 3rd Department of Clinical Medicine,Zhejiang University School of Medicine,Hangzhou 310058,China)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2018年第11期853-857,共5页 Chinese Journal of Laboratory Medicine
基金 浙江省医药卫生科研基金(2017KY698)
关键词 胸水 血蛋白质类 载体蛋白质类 抗微生物阳离子肽类 肺炎 胸腔积液 诊断 鉴别 Hydrothorax Blood proteins Carrier protein Antimicrobial cationic peptides Pneumonia Pleural effusion Diagnosis differential
  • 相关文献

参考文献12

二级参考文献121

  • 1吴腾飞,陈福广,黄清华,陈伟,邓旭明,张巧灵,刘波.中性粒细胞杀灭病原体的新途径:胞外诱捕网[J].免疫学杂志,2013,29(2):173-176. 被引量:7
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 3Garcia Vazquez E, Martinez JA, Mensa J, et al. C-reactive protein levels in community-acquired pneumonia[ J]. Eur Respir,2003,21 (4) :702 -705.
  • 4Hohenthal U, Hurme S, Helenius H, et al . Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia [J].Clin Mierobiol Infect, 2009, 15 (11) :1026 -32. Epub 2009 Jun 22.
  • 5Thiem U, Niklaus D, Sehlhoff B, et al. C-reactive protein, severity of pneumonia and mortality inelderly, hospitalised patients with community-acquired pneumonia[ J]. Age Ageing ,2009,38 (6) :693 - 697.
  • 6Querol-RibeUes JM, Tenias JM, Querol-Borras JM, et al . Valida- tion of the Pneumonia Severity Index for hospitalizing patients with community-acquired pneumonia[ J]. Med Clin (Bare) ,2004,122 (13) :481 -486.
  • 7van der Eerden MM, de Granff CS, Bronsveld W, et al. Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia [J]. Respir Med, 2004,98 (9) :872 - 878.
  • 8Roberts ME, Neville E, Berrisford RG, et al. Management of a malig- nant pleural effusion: British Thoracic Society Pleura]. Disease Guideline 2010 [ J ]. Thorax,2010,65 ( Suppl 2 ) : ii32 - 40.
  • 9Luo L, Shi HZ, Liang QL, et al. Diagnostic accuracy of serum me- sothelin for malignant mesothelioma: a meta-analysis [ J]. Respir Med ,2010,104 : 149 - 156.
  • 10Parulekar W, Di Primio G, Matzinger F, et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions [J]. Chest ,2001,120 : 19 - 25.

共引文献272

同被引文献168

引证文献16

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部